Cargando…
A triple combination of treatments on moderate COVID-19
OBJECTIVE: A triple combination of interferon (IFN) α-2b, lopinavir tablets, and umifenovir was used to treat COVID-19 patients. It is important to explore whether the benefit of this therapy is time dependent. METHODS: A cohort of moderate COVID-19 patients (n = 54) was admitted for hospitalization...
Autores principales: | Bao, ChunMiao, Li, BinBin, Zhou, YuFeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122460/ https://www.ncbi.nlm.nih.gov/pubmed/34027106 http://dx.doi.org/10.1515/med-2021-0279 |
Ejemplares similares
-
COVID-19 cases with delayed absorption of lung lesion
por: Li, BinBin, et al.
Publicado: (2021) -
Disparity in clinical characteristics between 2019 novel coronavirus pneumonia and leptospirosis
por: Li, BinBin, et al.
Publicado: (2021) -
High incidence of venous thrombosis in patients with moderate-to-severe COVID-19
por: Kerbikov, Oleg, et al.
Publicado: (2021) -
FXR suppresses colorectal cancer by inhibiting the Wnt/β-catenin pathway via activation of TLE3
por: Dong, Xingchen, et al.
Publicado: (2022) -
Transient leukocytopenia following combination therapy for COVID-19
por: Tsuchiya, Kazuo, et al.
Publicado: (2022)